Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33560862.
- Also identified by DOI 10.7326/M20-8101 and PMC identifier 7983309.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinicians must have access to the best available evidence to inform point-of-care decisions about the use of remdesivir in patients with COVID-19. This article provides updated advice from the American College of Physicians for clinicians based on an updated rapid review.
Medical subject headings
- Adenosine Monophosphate
- Alanine
- Antiviral Agents
- Pneumonia, Viral
- COVID-19 Drug Treatment